Sunridge Schedules Public Conference Call

Dec 03, 2010, 12:35 ET from Sunridge International

FOUNTAIN HILLS, Ariz., Dec. 3, 2010 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that its CEO G. Richard Smith will conduct a public conference call on Monday December 6, 2010 at 4:30 EST.  The purpose of the call is to provide a short update on the company's current and future activities.  The call will be open to the public and a question and answer period will be included.  If you are interested in participating please email us at so that we can forward you the call in number.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International


Jeff Smith, Sunridge International

T:  +1-480-837-6165



Victor Webb, Marston Webb International

T: (212) 684-6601


SOURCE Sunridge International